Genistein and cAMP signaling in vascular endothelium
Genistein and cAMP signaling in vascular endothelium
批准号:
7491164
负责人:
DONGMIN LIU
金额:
$23.47万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2010-04-30
关键词:
AddressAdenylate CyclaseAdhesionsAgingAmericanAnimalsArteriosclerosisBiochemicalBiologicalBiological AssayBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular systemCell ProliferationCell membraneCellsChronicConditionCyclic AMPCyclic AMP-Dependent Protein KinasesCytoskeletal ModelingDataDepressed moodDevelopmentDiseaseDoseElevationEndothelial CellsEstrogen ReceptorsEventExtravasationFoundationsFunctional disorderGTP-Binding ProteinsGasesGene ExpressionGenetic TranscriptionGenisteinGenomicsGoalsHealthHealth BenefitHypertensionHypotensionIngestionInterventionIsoflavonesLeukocytesMediatingMediationMessenger RNAMethodsMicroscopeMolecularMorbidity - disease rateNitric OxideNitric Oxide SynthaseNutraceuticalPathway interactionsPermeabilityPhysiologicalPlayPolymerase Chain ReactionPopulationPreventiveProcessProductionProtein BiosynthesisProtein Tyrosine KinaseProteinsPublic HealthRNARangeRattusResearchRibonucleasesRoleSignal PathwaySignal TransductionSignaling MoleculeSmooth Muscle MyocytesSoy ProteinsSystemTestingTherapeuticThrombinTimeVascular DiseasesVascular Endothelial CellVascular Endotheliumanalogbasecellular targetingdietary supplementshuman NOS3 proteinimmunocytochemistrymonolayernon-genomicnovelpromoterprotective effectprotein expressionsoysoy protein isolatevasoactive agent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-range goal of this research is to develop novel vasoactive agents that may be of benefit in lowering the high level of cardiovascular morbidity in the aging American population. Recent studies have shown that ingestion of soy protein associated with isoflavones may have a protective role in vasculature. Genistein, the major soy isoflavone, has various biologgical actions. However, it is not clear whether the beneficial effect of soy protein is due to genistein or other components. In addition, the cellular or molecular mechanisms underlying the vessel protective effect of soy products remain unclear. We recently found that genistein directly acts on vascular dothelial cells (EC), leading to cAMP accumulation, nitric oxide synthase (eNOS) activation and expression. Further, We demonstrated that genistein induced a rapid decrease in systemic blood pressure (BP) in rats. The objective of this application, is therefore to determine how genistein triggers the cAMP signaling pathway and thereby influencing the cAMP-related vascular function. The four following questions will be addressed: 1). How does genistein elevate cAMP, activate eNOS, and consequently stimulate nitric oxide in EC? 2) Does genistein decrease BP in animals through activation of the cAMP signaling? 3). Does elevated cAMP by genistein also alter eNOS gene expression ? 4). Does genistein protect endothelial barrier function via the cAMP signaling? We will employ cellular, molecular and biochemical analysis to determine whether genistein elevates cAMP via activation of Gs-mediated adenylate cyclase in EC. Genistein-regulated eNOS gene expression will be evaluated by ribonuclease protection assay and Real-Time PCR. The effect of genistein on endothelial barrier function, as determined by cytoskeletal reorganization and barrier permeability, will be assessed using immunocytochemistry, confocal microscope and macromolecular leakage methods. Pharmacological and molecular intervention approaches will be used to detemine the involvement of a specific pathway in mediation of genistein action. The results from these studies will establish the mechanisms of the genistein action in vasculature and thereby provide foundation for further studies to determine the effects of genistein on vascular health and diseases such as hypertension. The demonstration of the health benefits of soy isoflavones in vasculature is expected to have significant effect on public health since isoflavones are widely used as a dietary supplements.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Isoflavone genistein protects human vascular endothelial cells against tumor necrosis factor-alpha-induced apoptosis through the p38beta mitogen-activated protein kinase.
异黄酮染料木黄酮通过p38beta促丝分裂原激活的蛋白激酶保护人血管内皮细胞免受肿瘤坏死因子 - α诱导的凋亡。
DOI:
10.1007/s10495-008-0283-9
发表时间:
2009-01
期刊:
APOPTOSIS
影响因子:
7.2
作者:
[Si, Hongwei, Liu, Dongmin]
通讯作者:
Liu, Dongmin
DOI:
10.2174/092986708785132979
发表时间:
2008-07
期刊:
Current medicinal chemistry
影响因子:
4.1
作者:
[P. V. A. Babu;Dongmin Liu]
通讯作者:
P. V. A. Babu;Dongmin Liu
DOI:
10.1139/h2012-005
发表时间:
2012-06
期刊:
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
影响因子:
--
作者:
[Fu Z, Gilbert ER, Pfeiffer L, Zhang Y, Fu Y, Liu D]
通讯作者:
Liu D
DOI:
10.1007/s00394-013-0525-7
发表时间:
2014-02
期刊:
European journal of nutrition
影响因子:
5
作者:
[Si H, Wyeth RP, Liu D]
通讯作者:
Liu D
Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.
DOI:
10.1017/s0007114510004824
发表时间:
2011-04
期刊:
BRITISH JOURNAL OF NUTRITION
影响因子:
3.6
作者:
[Fu, Zhuo, Zhen, Wei, Yuskavage, Julia, Liu, Dongmin]
通讯作者:
Liu, Dongmin
共 6 条
Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity
-
批准号:10737170
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2023
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8820798
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8234308
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8427297
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8619589
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Genistein for the prevention and treatment of diabetic vascular inflammation
-
批准号:7816316
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2009
-
负责人:DONGMIN LIU
-
依托单位:
Genistein for the Prevention and Treatment of Diabetic Vascular Inflammation
-
批准号:7509977
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2008
-
负责人:DONGMIN LIU
-
依托单位:
Genistein for the Prevention and Treatment of Diabetic Vascular Inflammation
-
批准号:7686348
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2008
-
负责人:DONGMIN LIU
-
依托单位:
Genistein and cAMP signaling in vascular endothelium
-
批准号:7140738
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2007
-
负责人:DONGMIN LIU
-
依托单位:
海外基金